Medicinal Genomics

About:

Medicinal Genomics is pioneering the genomics of medical cannabis and hemp.

Website: http://www.medicinalgenomics.com

Twitter/X: medigenomics

Description:

Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largest DNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.

Total Funding Amount:

$2.68M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2011-01-01

Founders:

Kevin McKernan

Number of Employees:

11-50

Last Funding Date:

2021-04-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai